Despite the association of BARD1 with breast cancer risk27, gnomAD data suggest a greater tolerance for loss-of function variants in BARD1 (observed/expected ratio = 1.03 (90% Confidence Interval = 0.79–1.36)). The gene discussed is BARD1; the disease is breast carcinoma.